Zhangying Feng

The Fourth Hospital Of Hebei Medical University 12 Jiankang Road Shijiazhuang 050011 People's Republic Of China +86-311-86296233
Hebei, 862962, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Method development and validation for determination of entinostat in human plasma and its application in breast cancer patients.

Method development and validation for determination of entinostat in human plasma and its application in breast cancer patients.

Journal: RSC advances

Published: April 28, 2026

Population Pharmacokinetics and Dose Optimization of Vancomycin in Adult Cancer Patients.

Population Pharmacokinetics and Dose Optimization of Vancomycin in Adult Cancer Patients.

Journal: Drug design, development and therapy

Published: March 10, 2026

Determination of Total and Free Plasma Concentration of Liposomal Mitoxantrone and Clinical Application in Adult Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma.

Determination of Total and Free Plasma Concentration of Liposomal Mitoxantrone and Clinical Application in Adult Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma.

Journal: Drug design, development and therapy

Published: May 22, 2025

Determination of furmonertinib in human plasma and cerebrospinal fluid by UPLC-MS/MS: Application in lung cancer patients with and without brain metastasis.

Determination of furmonertinib in human plasma and cerebrospinal fluid by UPLC-MS/MS: Application in lung cancer patients with and without brain metastasis.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: September 08, 2024

Evaluation of pharmacokinetics and relative bioavailability of pentoxifylline and its metabolite in beagle dogs following different formulations.

Evaluation of pharmacokinetics and relative bioavailability of pentoxifylline and its metabolite in beagle dogs following different formulations.

Journal: Frontiers in pharmacology

Published: August 29, 2024

Simultaneous determination of icotinib, osimertinib, aumolertinib, and anlotinib in human plasma for therapeutic drug monitoring by UPLC-MS/MS.

Simultaneous determination of icotinib, osimertinib, aumolertinib, and anlotinib in human plasma for therapeutic drug monitoring by UPLC-MS/MS.

Journal: Journal of pharmaceutical and biomedical analysis

Published: June 12, 2024

Population pharmacokinetics of nalbuphine in patients undergoing general anesthesia surgery.

Population pharmacokinetics of nalbuphine in patients undergoing general anesthesia surgery.

Journal: Frontiers in pharmacology

Published: December 23, 2022

A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma.

A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma.

Journal: Drug design, development and therapy

Published: August 23, 2021

Determining novel candidate anti-hepatocellular carcinoma drugs using interaction networks and molecular docking between drug targets and natural compounds of SiNiSan.

Determining novel candidate anti-hepatocellular carcinoma drugs using interaction networks and molecular docking between drug targets and natural compounds of SiNiSan.

Journal: PeerJ

Published: May 04, 2020

Effects of multidose simvastatin co-administration on pharmacokinetic profile of apatinib in rats by UPLC-MS/MS.

Effects of multidose simvastatin co-administration on pharmacokinetic profile of apatinib in rats by UPLC-MS/MS.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: March 10, 2020

Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis.

Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis.

Journal: BMC cancer

Published: May 21, 2019

Quantification of 1D, a novel derivative of curcumin with potential antitumor activity, in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study in rats.

Quantification of 1D, a novel derivative of curcumin with potential antitumor activity, in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study in rats.

Journal: Pharmaceutical biology

Published: April 25, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026